Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07447076) titled 'Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)' on Feb. 25.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Sabine Mueller, MD, PhD

Condition: Recurrent Atypical Teratoid/Rhabdoid Tumor Atypical Teratoid/Rhabdoid Tumor (ATRT) of the CNS

Intervention: Procedure: Lumber Puncture Procedure: Blood Specimen Collection Procedure: Magnetic resonance imaging (MRI) Drug: Gemcitabine Drug: Paxalisib

Recruitment Status: Not re...